PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|September 2, 2016
- Pharmaceutical Technology-09-02-2016
- Volume 40
- Issue 9
Liquid Handling System for Automatic Particle Characterization
The FlowCam ALH automated liquid handling system from Fluid Imaging Technologies is a particle imaging and analysis system that automatically detects, images, and characterizes individual particles and microorganisms.
Advertisement
The FlowCam ALH automated liquid handling system from Fluid Imaging Technologies is a particle imaging and analysis system that automatically detects, images, and characterizes individual particles and microorganisms. The automated liquid handling system can process up to 96 samples per run without requiring human intervention. The system can be used for particle characterization and quality control in protein therapeutics, drug development, and production. The FlowCam autosampler includes built-in mixing, heating, and cooling for sample conditioning, control over evaporation, and protection against sample degradation. The system is self-contained in a protective enclosure suitable for cleanrooms.
Articles in this issue
about 10 years ago
The Internet of Things for Pharmaceutical Manufacturingabout 10 years ago
How to Get the Most Out of Facility Renovationsabout 10 years ago
Root Cause Analysis–Finding the Root of the Problemabout 10 years ago
New Directions in Modular Manufacturingabout 10 years ago
Efforts Accelerate to Streamline Postapproval Change Processabout 10 years ago
Common Deficiencies in ANDAs for Dermatologic Drug Productsabout 10 years ago
Maintaining Hygienic Diaphragm Valvesabout 10 years ago
Tumble Blenders Include Improved Safety Featuresabout 10 years ago
Analyzer Automates Cell-Culture Chemistry Analysisabout 10 years ago
Data Logger Provides Ultra-Low Temperature ReadingsAdvertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement